Study of the mechanism of lung vascular permeability in pulmonary edema
Study of the mechanism of lung vascular permeability in pulmonary edema
批准号:
09470325
负责人:
SHIMADA Yasuhiro
金额:
$9.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999
中文摘要
已知多种化学介质导致通透性肺水肿的发生。我们采用大鼠枕大池注射纤维蛋白原和凝血酶的方法探讨神经源性肺水肿的发生机制,发现交感神经末梢同时释放神经肽Y(NPY)和神经激肽A可增加肺血管通透性。在NPY方面,我们报道了一项开创性的工作,通过使用隔离的肺灌流模型和刺激交感神经,证明NPY是一种通透性物质。我们还阐明了在相同的模型中,气管内给予NPY可剂量依赖性地增加肺血管通透性。在接下来的研究中,我们发现NPY同时存在于肺泡巨噬细胞和水肿液中,其浓度是免疫组织化学方法检测到的血浆浓度的1000倍。提示神经源性肺水肿的发生机制可能与交感神经末梢释放NPY等化学介质有关,与中枢神经系统的NO有关。在一项对几天前切断迷走神经的大鼠的初步研究中,神经源性肺水肿完全避免了。虽然确切的机制尚不清楚,但神经源性肺水肿的发生可能与中枢神经系统的NO和周围交感神经末梢的NPY的作用密切相关。
英文摘要
A variety of chemical mediators has been known to be responsible for the development of permeability pulmonary edema. We have been investigating the mechanisms of neurogenic pulmonary edema by using a rat model in which fibrinogen and thrombin are injected into the cisterna magna (neurogenic pulmonary edema model), and have found that neuropeptide Y (NPY) and neurokinin A, simultaneously released from the sympathetic nerve terminal, increase pulmonary vascular permeability. In terms of NPY, we reported a pioneer work in which NPY is proved to be one of the permeability substances by using an isolated perfused lung model and stimulating the sympathetic nerve. We also clarified that NPY administered intratracheally increases lung vascular permeability dose-despondently in the same model. In the following study, we have found that NPY is present both in the edema fluid and in alveolar macrophages and the concentration is 1000 times higher than that found in plasma by using an immunohistochemical method.In the present study, we have meticulously studied the effect of nitric oxide (NO) on the development of pulmonary edema. The present results may suggest that the mechanism of neurogenic pulmonary edema is peripherally related to the release of chemical mediators such as NPY from the sympathetic nerve terminal, and centrally related to NO in the central nervous system. Also in a preliminary study of rats in which the vagus nerve was severed several days before, neurogenic pulmonary edema was completely avoided. Although the precise mechanism is still not clear, the development of neurogenic pulmonary edema may be closely related to the effects of NO in the central nervous system and NPY in the peripheral sympathetic nerve terminal.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
藤原祥裕: "Transfer function analysis of the circulation in patients undergoing sevoflurane anesthesia"Can J Anesth. 46. 820-825 (1999)
Yoshihiro Fujiwara:“接受七氟醚麻醉的患者循环的传递函数分析”Can J Anesth 46. 820-825 (1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kimura, T: "Heart rate and blood pressure power spectral analysis during calcium channel blocker induced hypotension"Canadian Journal of Anesthesia. 46. 1110-1116 (1999)
Kimura, T:“钙通道阻滞剂引起的低血压期间的心率和血压功率谱分析”加拿大麻醉杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yamashita, A: "Effects of neuropeptide Y on pulmonary vascular permeability and its receptor subtype in rats"11th World Congress of Anaesthesiologists, Abstract Book. 246. (1996)
Yamashita,A:“神经肽 Y 对大鼠肺血管通透性及其受体亚型的影响”第 11 届世界麻醉医师大会,摘要书。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
山下明子: "Effects of neuropeptide Y on pulmonary vascular permeability and its receptor"11th World Congress of Anaesthesiologists, Abstract Book. 246. (1996)
Akiko Yamashita:“神经肽 Y 对肺血管通透性及其受体的影响”第 11 届世界麻醉医师大会,摘要书 246。(1996 年)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
木村智政: "Heart rate and blood pressure power spectral analysis during calcium channel blocker induced hypotension"Can J Anesth. 46. 1110-1116 (1999)
Tomomasa Kimura:“钙通道阻滞剂引起的低血压期间的心率和血压功率谱分析”Can J Anesth. 46. 1110-1116 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 30 条
Mechanisms of increased vascular permeability associated with sympathetic excitability and the development of treatment strategy of ARDS.
-
批准号:16390448
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.94万
-
财政年份:2004
-
负责人:SHIMADA Yasuhiro
-
依托单位:
Study on the Neural Network relating to Pulmonary Vascular Permeability and Cloning of its Receptor
-
批准号:12470318
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.47万
-
财政年份:2000
-
负责人:SHIMADA Yasuhiro
-
依托单位:
Study on the Mechanism of Increased Vascular Permeability in Pulmonary Edema
-
批准号:06454443
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.54万
-
财政年份:1994
-
负责人:SHIMADA Yasuhiro
-
依托单位:
Inhalation anesthetics and oncogene
-
批准号:01440063
-
项目类别:Grant-in-Aid for General Scientific Research (A)
-
资助金额:$10.43万
-
财政年份:1989
-
负责人:SHIMADA Yasuhiro
-
依托单位:
Mechanism and the Effects of Anesthetics and Anesthetic Depth on the Development of Neurogenic Pulmonary Edema.
-
批准号:61480332
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.35万
-
财政年份:1986
-
负责人:SHIMADA Yasuhiro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
RGD-68Ga@AuNCs PET监测PRMT5通过VEGFA调节肺腺癌血管新生的功能及机制
-
批准号:82372007
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:谢文晖
-
依托单位:
基于密度泛函理论金原子簇放射性药物设计、制备及其在肺癌诊疗中的应用研究
-
批准号:82371997
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张春富
-
依托单位:
IL-33调控EOMES+Tr1样细胞分化介导EGFR突变肺癌免疫逃逸的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:周斐
-
依托单位:
脂肪酸合成通过GDF15/IRS2介导胰岛素抵抗促进血管内皮细胞活化导致脓毒症肺损伤的机制研究
-
批准号:82372203
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李然然
-
依托单位:
(11)C标记tariquidar及表达P-糖蛋白的耐药性肺癌PET显像
-
批准号:81101776
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:刘俊
-
依托单位:
非吸烟肺癌表皮生长因子受体基因相关非编码小RNA差异表达研究
-
批准号:81071914
-
项目类别:面上项目
-
资助金额:36.0万元
-
批准年份:2010
-
负责人:钱碧云
-
依托单位:
肢体缺血后适应抑制肺泡巨噬细胞活化及防治肺缺血再灌注损伤机制的研究
-
批准号:81070041
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:甘辉立
-
依托单位:
常山酮增强肺癌放疗效果同时预防放射性肺损伤的分子机制研究
-
批准号:30970864
-
项目类别:面上项目
-
资助金额:29.0万元
-
批准年份:2009
-
负责人:赵路军
-
依托单位:
Endoglin基因修饰肿瘤/DC杂交细胞诱生靶向特异性抗人肺癌CTL疫苗的研究
-
批准号:30760248
-
项目类别:地区科学基金项目
-
资助金额:16.0万元
-
批准年份:2007
-
负责人:周源
-
依托单位:
与肺癌细胞侵袭相关的microRNAs研究
-
批准号:30771187
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2007
-
负责人:罗泽伟
-
依托单位: